GNH USA

Europe — EMA

Lg-Octaplas

GNH USA supplies Lg-Octaplas (Human plasma protein), a plasma protein fraction for replacement therapy of coagulation factor deficiencies, massive hemorrhage

Human Plasma Protein

Request sourcing

1
Pack/s

What is Human Plasma Protein?

Human plasma protein, the active ingredient in Lg-Octaplas, is a plasma protein fraction presented as a lyophilized powder for intravenous use. It provides replacement therapy for coagulation factor deficiencies and supports plasma volume in patients with massive hemorrhage or surgical trauma.

GNH USA supplies Lg-Octaplas as a licensed, GDP-compliant international pharmaceutical supplier serving hospitals worldwide.

What is Human Plasma Protein used for?

Lg-Octaplas is used in the management of disorders affecting coagulation and plasma volume.

Replacement therapy for coagulation factor deficiencies: restores deficient clotting factors to improve hemostasis. Massive hemorrhage control: supplies plasma proteins to control bleeding and maintain circulatory volume. Plasma volume replacement in surgical or trauma settings: expands intravascular volume to support perfusion.

What are the side effects of Human Plasma Protein?

Lg-Octaplas may be associated with adverse reactions typical of plasma‑derived products.

Common Side Effects: - Allergic reaction: mild urticaria or rash. - Fever: transient increase in body temperature. - Headache: mild to moderate headache. - Nausea: occasional nausea.

Serious or Rare Side Effects: - Anaphylaxis: severe, potentially life‑threatening hypersensitivity. - Transfusion‑related acute lung injury (TRALI): acute respiratory distress. - Transmission of infectious agents: rare risk of viral contamination. - Thromboembolic events: clot formation in vessels.

What precautions apply to Human Plasma Protein?

When using Lg-Octaplas, clinicians should observe several safety measures.

Allergy assessment: verify no known hypersensitivity to human plasma proteins. Infection screening: ensure donor screening and product viral inactivation have been performed. Volume overload: monitor patients with cardiac or renal insufficiency. Coagulopathy monitoring: check coagulation parameters before and after infusion. Pregnancy and lactation: use only if benefit outweighs risk, as safety data are limited. Store at 2-8°C: keep refrigerated, protect from light, do not freeze or shake.

What does Human Plasma Protein interact with?

Lg-Octaplas can interact with other medications that affect hemostasis or fluid balance.

Major Interactions (Avoid): - Concomitant anticoagulants (e.g., warfarin, heparin): may increase bleeding risk. - High‑dose fibrinolytics: may exacerbate coagulopathy. - Other plasma‑derived products: risk of volume overload.

Moderate Interactions (Monitor Closely): - Immunosuppressants: monitor for altered immune response. - Renal replacement therapy: adjust volume status monitoring. - Diuretics: watch for electrolyte shifts.

Frequently asked questions

What is Lg-Octaplas used for?+
Lg-Octaplas is a plasma‑derived product indicated for replacement therapy in patients with deficiencies of coagulation factors, for control of massive bleeding, and for plasma volume expansion during surgery or trauma. It supplies a broad range of plasma proteins to support hemostasis and circulatory stability.
How does human plasma protein work?+
Human plasma protein in Lg-Octaplas provides fibrinogen, prothrombin, and multiple clotting factors together with albumin and globulins. When administered intravenously, these proteins replenish deficient factors, enhance clot formation, and increase oncotic pressure, thereby helping to stop bleeding and restore intravascular volume.
What is the usual dose of Lg-Octaplas?+
The dose of Lg-Octaplas is individualized and determined by the prescribing clinician based on the patient’s specific coagulation deficit, body weight, severity of bleeding, and clinical setting. Dosing calculations are performed by the healthcare professional and are not standardized in public literature.
Is Lg-Octaplas safe in pregnancy or breastfeeding?+
Safety data for Lg-Octaplas in pregnancy and lactation are limited; the product should be used only when the potential benefit to the mother outweighs any possible risk to the fetus or infant. Clinicians should assess each case carefully and follow local regulatory guidance.
How do I order Lg-Octaplas from GNH USA?+
To place an order, submit an enquiry on the product page at gnh-usa.com specifying the required quantity of Lg-Octaplas. GNH USA works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including cold‑chain if needed) and required import documentation.
How does Lg-Octaplas compare with other plasma products?+
Lg-Octaplas is a lyophilized plasma protein fraction that offers a broad spectrum of clotting factors in a stable, reconstitutable form, whereas fresh frozen plasma provides whole plasma but requires cold storage and rapid use. Compared with specific factor concentrates, Lg-Octaplas delivers multiple factors simultaneously, which can be advantageous in complex coagulopathies or massive bleeding.
What are the storage requirements for Lg-Octaplas?+
Lg-Octaplas should be stored at 2‑8 °C in a refrigerator, protected from light, and must not be frozen or shaken. The lyophilized powder remains stable until reconstitution; once reconstituted, it should be used promptly according to the product’s prescribing information and discarded if not used within the recommended time frame.
How is Lg-Octaplas administered?+
Lg-Octaplas is supplied as a lyophilized powder that must be reconstituted with the appropriate diluent under aseptic conditions. The resulting solution is administered by intravenous infusion, typically through a peripheral or central line, with infusion rates adjusted by the treating physician based on the patient’s clinical response and tolerance.
What are the most serious risks to watch for with Lg-Octaplas?+
The most serious adverse events linked to Lg-Octaplas include severe allergic reactions such as anaphylaxis, transfusion‑related acute lung injury (TRALI), and rare transmission of infectious agents despite rigorous donor screening. Clinicians should monitor patients closely for signs of respiratory distress, hypotension, or unexpected bleeding during and after infusion.
Who should not use Lg-Octaplas?+
Lg-Octaplas is contraindicated in individuals with known hypersensitivity to human plasma proteins or any of the product’s excipients. It should also be avoided in patients with a history of severe anaphylactic reactions to plasma‑derived therapies, and used with caution in those with uncontrolled volume overload, severe cardiac or renal failure, unless the clinical benefit justifies the risk.
Information provided on this page is for educational use by procurement and clinical professionals. Always consult a licensed healthcare provider for medical advice and prescribing decisions. GNH USA supplies this product subject to applicable regulatory and licensing requirements.
Send a sourcing enquiry for this product →

Product details

Drug
Human Plasma Protein
Route
Intravenous Use
Manufacturer
Octapharma (Ip) Sprl
Origin
EU

Related products

A

A

Liquid Extract From Viscum Album Subsp. Abietis Var Abies Alba (1:20), Extraction Solvents: Water Fo

Helixor Heilmittel Gmbh
EU
A

A

Liquid Extract From Viscum Album Subsp. Abietis Var Abies Alba (1:20), Extraction Solvents: Water Fo

Helixor Heilmittel Gmbh
EU
A

A

Liquid Extract From Viscum Album Subsp. Abietis Var Abies Alba (1:20), Extraction Solvents: Water Fo

Helixor Heilmittel Gmbh
EU
A

A

Liquid Extract From Viscum Album Subsp. Abietis Var Abies Alba (1:20), Extraction Solvents: Water Fo

Helixor Heilmittel Gmbh
EU